Cargando…

Lymph Node Dissection for Differentiated Thyroid Cancer

Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizrachi, Aviram, Shaha, Ashok R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283708/
https://www.ncbi.nlm.nih.gov/pubmed/28117285
http://dx.doi.org/10.4274/2017.26.suppl.02
_version_ 1782503537325899776
author Mizrachi, Aviram
Shaha, Ashok R.
author_facet Mizrachi, Aviram
Shaha, Ashok R.
author_sort Mizrachi, Aviram
collection PubMed
description Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not advocated with exception of central neck dissection for locally advanced tumors. When regarding recurrent disease, foundations have been laid for clinicians to make accurate decisions as to when to perform surgery and when to continue maintaining the patient’s disease under observation. These complex decisions are determined based upon multiple factors, not only regarding the patient’s disease but also the patient’s comprehension of the procedure and apprehension levels. Nevertheless if the patient and/or clinician are emotionally keen to surgically remove the disease then the procedure should be considered.
format Online
Article
Text
id pubmed-5283708
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-52837082017-03-27 Lymph Node Dissection for Differentiated Thyroid Cancer Mizrachi, Aviram Shaha, Ashok R. Mol Imaging Radionucl Ther Review Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not advocated with exception of central neck dissection for locally advanced tumors. When regarding recurrent disease, foundations have been laid for clinicians to make accurate decisions as to when to perform surgery and when to continue maintaining the patient’s disease under observation. These complex decisions are determined based upon multiple factors, not only regarding the patient’s disease but also the patient’s comprehension of the procedure and apprehension levels. Nevertheless if the patient and/or clinician are emotionally keen to surgically remove the disease then the procedure should be considered. Galenos Publishing 2017-02 2017-01-09 /pmc/articles/PMC5283708/ /pubmed/28117285 http://dx.doi.org/10.4274/2017.26.suppl.02 Text en © Molecular Imaging and Radionuclide Therapy, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Mizrachi, Aviram
Shaha, Ashok R.
Lymph Node Dissection for Differentiated Thyroid Cancer
title Lymph Node Dissection for Differentiated Thyroid Cancer
title_full Lymph Node Dissection for Differentiated Thyroid Cancer
title_fullStr Lymph Node Dissection for Differentiated Thyroid Cancer
title_full_unstemmed Lymph Node Dissection for Differentiated Thyroid Cancer
title_short Lymph Node Dissection for Differentiated Thyroid Cancer
title_sort lymph node dissection for differentiated thyroid cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283708/
https://www.ncbi.nlm.nih.gov/pubmed/28117285
http://dx.doi.org/10.4274/2017.26.suppl.02
work_keys_str_mv AT mizrachiaviram lymphnodedissectionfordifferentiatedthyroidcancer
AT shahaashokr lymphnodedissectionfordifferentiatedthyroidcancer